BetterLife Pharma (BETRF) Price to Earnings (2011 - 2026)
BetterLife Pharma (BETRF) posted Price to Earnings of 17.09 for Q2 2026, up 39.62% on a QoQ basis from 28.3 in Q3 2025, and up 70.91% year-over-year from 10.0 in Q2 2025.
Analysis
BetterLife Pharma (BETRF) Price to Earnings (2011 - 2026) Analysis & Trends
BetterLife Pharma has reported Price to Earnings for 13 years, with the latest figure at 17.09 in Q2 2026.
- On a quarterly basis, Price to Earnings rose 70.91% year-over-year to 17.09 in Q2 2026; TTM through Apr 2026 was 5.16, a 24.45% increase from a year earlier, with the FY2026 full-year figure at 5.67, down 11.74% from the prior year.
- Price to Earnings was 17.09 for Q2 2026 at BetterLife Pharma, up from 28.3 in the prior quarter.
- The five-year high for Price to Earnings was 18.6 in Q4 2024, with the low at 58.75 in Q2 2025.
- Average Price to Earnings over 5 years is 14.63, with a median of 11.5 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Price to Earnings sank 844.83% in 2023, then surged 161.95% in 2024.
- Over 5 years, Price to Earnings stood at 3.18 in 2022, then tumbled by 844.83% to 30.02 in 2023, then soared by 161.95% to 18.6 in 2024, then tumbled by 252.14% to 28.3 in 2025, then surged by 39.62% to 17.09 in 2026.
- The last three Price to Earnings figures came in at 17.09 (Q2 2026), 28.3 (Q3 2025), and 58.75 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -17.09 |
| Jul 31, 2025 | -28.30 |
| Apr 30, 2025 | -58.75 |
| Jan 31, 2025 | -25.27 |
| Oct 31, 2024 | 18.60 |
| Jul 31, 2024 | -12.25 |
| Apr 30, 2024 | -6.52 |
| Jan 31, 2024 | -7.29 |
| Oct 31, 2023 | -30.02 |
| Jul 31, 2023 | -5.67 |
| Apr 30, 2023 | -18.90 |
| Jan 31, 2023 | -20.41 |
| Oct 31, 2022 | -3.18 |
| Jul 31, 2022 | -10.74 |
| Apr 30, 2022 | -3.97 |
| Jan 31, 2022 | -4.38 |
| Oct 31, 2021 | -3.54 |
| Jul 31, 2021 | -2.33 |
| Apr 30, 2019 | -237.39 |
| Oct 31, 2018 | -198.27 |